Inherited fibrinolytic defects

Description

A disease caused by genetically inherited mutations affecting the fibrinolysis system which prevents blood clots from growing and becoming problematic. This disease is characterised by defects in the fibrinolysis system leading to coagulation of the blood. This disease may present with thrombosis.

Exclusions from above levels

JA43.3 – Postpartum coagulation defects
04 – Diseases of the immune system
05 – Endocrine, nutritional or metabolic diseases

Show allHide

18 – Complications of pregnancy, childbirth or the puerperium
19 – Certain conditions originating in the perinatal period
20 – Congenital malformations, deformations or chromosomal abnormalities
22 – Injury, poisoning or certain other consequences of external causes
http://id.who.int/icd/entity/1000704511 – Human immunodeficiency virus disease
JB64.1 – Other diseases of the blood or blood-forming organs or certain disorders involving the immune mechanism complicating pregnancy, childbirth or the puerperium

Child codes

3B50.0 – Congenital alpha-2 antiplasmin deficiency
3B50.1 – Congenital plasminogen activator inhibitor type 1 deficiency
3B50.Y – Other specified inherited fibrinolytic defects
3B50.Z – Inherited fibrinolytic defects, unspecified

Foundation children elsewhere

DA0D.3 – Hypoplasminogenaemia

Sibling codes

3B51 – Acquired fibrinolytic defects

Foundation entity

Inherited fibrinolytic defects – http://id.who.int/icd/entity/1502898025

Part of: 03: Diseases of the blood or blood-forming organs